High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial
Not available.
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Ferrata Storti Foundation
2025-01-01
|
Series: | Haematologica |
Online Access: | https://haematologica.org/article/view/11922 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832577678480244736 |
---|---|
author | Margot S. F. Roeten Johan van Meerloo Suzanne N. van Dijk Zinia Kwidama Gaye Jenkins David T. Teachey Meenakshi Devidas Mignon L. Loh Gertjan J. L. Kaspers Sonja Zweegman Gerrit Jansen Terzah M. Horton Jacqueline Cloos |
author_facet | Margot S. F. Roeten Johan van Meerloo Suzanne N. van Dijk Zinia Kwidama Gaye Jenkins David T. Teachey Meenakshi Devidas Mignon L. Loh Gertjan J. L. Kaspers Sonja Zweegman Gerrit Jansen Terzah M. Horton Jacqueline Cloos |
author_sort | Margot S. F. Roeten |
collection | DOAJ |
description |
Not available.
|
format | Article |
id | doaj-art-790dae2aa02c4dd79da29d72a2a02093 |
institution | Kabale University |
issn | 0390-6078 1592-8721 |
language | English |
publishDate | 2025-01-01 |
publisher | Ferrata Storti Foundation |
record_format | Article |
series | Haematologica |
spelling | doaj-art-790dae2aa02c4dd79da29d72a2a020932025-01-30T19:44:24ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-01-01999110.3324/haematol.2024.286171High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trialMargot S. F. Roeten0Johan van Meerloo1Suzanne N. van Dijk2Zinia Kwidama3Gaye Jenkins4David T. Teachey5Meenakshi Devidas6Mignon L. Loh7Gertjan J. L. Kaspers8Sonja Zweegman9Gerrit Jansen10Terzah M. Horton11Jacqueline Cloos12Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, AmsterdamDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, AmsterdamDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, AmsterdamDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, AmsterdamTexas Children's Hospital, Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine and Dan L. Duncan Cancer Center, Houston, TXDepartment of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PADepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TNDivision of Hematology, Oncology, BMT, and Cellular Therapies, Seattle Children’s Hospital, Seattle, WAPrincess Máxima Center of Pediatric Oncology, Utrecht, The Netherlands; Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, AmsterdamDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, AmsterdamAmsterdam Rheumatology and Immunology Center, Cancer Center Amsterdam, Amsterdam UMC, location Vrije Universiteit, AmsterdamTexas Children's Hospital, Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine and Dan L. Duncan Cancer Center, Houston, TXDepartment of Hematology, Cancer Center Amsterdam, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam Not available. https://haematologica.org/article/view/11922 |
spellingShingle | Margot S. F. Roeten Johan van Meerloo Suzanne N. van Dijk Zinia Kwidama Gaye Jenkins David T. Teachey Meenakshi Devidas Mignon L. Loh Gertjan J. L. Kaspers Sonja Zweegman Gerrit Jansen Terzah M. Horton Jacqueline Cloos High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial Haematologica |
title | High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial |
title_full | High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial |
title_fullStr | High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial |
title_full_unstemmed | High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial |
title_short | High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial |
title_sort | high immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib containing chemotherapy update from the children s oncology group aall1231 trial |
url | https://haematologica.org/article/view/11922 |
work_keys_str_mv | AT margotsfroeten highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT johanvanmeerloo highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT suzannenvandijk highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT ziniakwidama highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT gayejenkins highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT davidtteachey highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT meenakshidevidas highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT mignonlloh highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT gertjanjlkaspers highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT sonjazweegman highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT gerritjansen highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT terzahmhorton highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial AT jacquelinecloos highimmunoproteasomeandlowconstitutiveproteasomesubunitlevelscorrelatewithsensitivitytobortezomibcontainingchemotherapyupdatefromthechildrensoncologygroupaall1231trial |